We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




A More Comprehensive Approach to Identifying Patients with Mononucleosis

By LabMedica International staff writers
Posted on 10 May 2016
A new systematic review provides advice for earlier, more accurate diagnosis of patients with infectious mononucleosis to help expedite proper treatment.

Symptoms are of limited value for the diagnosis of mononucleosis; sore throat and fatigue are sensitive but nonspecific. More...
When mono patients present with enlarged tonsils and swollen glands, many physicians assume the issue is strep throat and prescribe antibiotics, completely useless against viral mono. "By overusing antibiotics, we increase resistance of bacteria," said study leader Mark H. Ebell, MD, MS, professor, College of Public Health, University of Georgia (Athens, GA, USA), "We waste money. We sometimes cause very serious adverse effects like allergic reactions or Clostridium difficile infection."

In addition to preventing the prescription of useless antibiotics, Prof. Ebell also wanted this study to inform the prognosis and recommendations given to patients after diagnosis. "I like to help doctors make the best use of their clinical skills, of the questions they ask, of the exam maneuvers they do, so they know what to focus on when they're seeing a patient," he said, "Also, we tend to focus a lot on diagnosis and treatment in medicine, but I think that the importance of making a good prognosis is underappreciated. Patients often ask: When am I going to feel better, doc?" For example, patients shouldn't expect to get out and play contact sports soon, as the virus enlarges the spleen (splenomegaly) and puts it at risk of rupturing.

In the 1990s, when Prof. Ebell first published on mono, "what I was struck by then was how limited the research was,” he said, "So I wanted to revisit that area and see if the research had improved over the past 20 years." Prof. Ebell and colleagues set out to systematically review studies involving the clinical diagnosis of mono. Their goal was to determine how clinicians can best use the presence of signs & symptoms and lab tests for white blood cell (WBC) counts.

Their review relied on articles from PubMed and EMBASE dating from 2015 back to 1966 and 1947, respectively. These articles were narrowed to 11 studies that allowed the researchers to look at effectiveness of physical exams and WBC count analysis in detecting mono in individual patients.

They found that the best predictors of mono were swollen posterior cervical or axillary lymph nodes, fatigue, and enlarged spleen, as well as % of a patient's WBCs that are lymphocytes or atypical lymphocytes. Having over 50% lymphocytes or 10% atypical lymphocytes greatly increased the likelihood of mono.

Prof. Ebell noted that the "literature is still pretty bad" when it comes to analyzing mono, but he plans to work in collaboration with UGA's University Health Center to: examine the accuracy of the Monospot test (a screening test for presence of viral antibodies in blood); evaluate the signs & symptoms of patients; and analyze individual patients’ prognoses over the course of illness.

The report, by Ebell MH et al, was published April 12, 2016, in the Journal of the American Medical Association (JAMA).

Related Links:
University of Georgia


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Electrolyte Analyzer
BKE-B
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.